Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | MMP12 | P39900 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7760312 | 0.79 | CTSD (0.32) | ALDH1A1TDP1 | |
| SCHEMBL10874824 | 0.78 | PAOX (0.37) | KDM4EALDH1A1TDP1CA2PTGS1 | |
| SCHEMBL8589436 | 0.74 | LMNA (0.33) | CA2NFKB1 | |
| SCHEMBL11542665 | 0.74 | PAOX (0.39) | KDM4EALDH1A1MAPK1HIF1APAOX | |
| SCHEMBL1953277 | 0.72 | EPHX1 (0.37) | ALDH1A1TDP1 | |
| SCHEMBL450522 | 0.71 | KDM4E (0.41) | KDM4EALDH1A1TDP1CA2PTGS1 | |
| SCHEMBL4555933 | 0.70 | ALDH1A1 (0.35) | KDM4EALDH1A1CA2PTGS1MMP12 | |
| SCHEMBL26965406 | 0.67 | KDM4E (0.44) | KDM4EALDH1A1TDP1CA2PTGS1 | |
| SCHEMBL2987964 | 0.67 | KDM4E (0.44) | KDM4EALDH1A1TDP1CA2PTGS1 | |
| SCHEMBL15123076 | 0.67 | ALDH1A1 (0.38) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102432862-A | Modified alkoxylation products having at least one non-terminal alkoxysilyl group, with increased storage life and increased stretchability of the polymers prepared using them | EVONIK GOLDSCHMIDT GMBH | 2012-05-02 | — | — | CN | claimed |
| US-6703497-B1 | SURFACE MODIFIED BY HAVING HYDROXYL FUNCTIONAL GROUPS PRESENT AT THE SURFACE ETHERIFIED BY ORGANIC COMPOUND COMPRISING SILYLATING AGENT, ISOCYANATE, HALOGENATED ALKYLATING AGENT, ALKYLENE OXIDE, OR GLYCIDYL COMPOUND | RHODIA CHIMIE (FR) | 2004-03-09 | — | — | US | claimed |
| US-20250091263-A1 | Low-Pore Pellets and Methods for Producing Molded Body | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-03-20 | — | — | US | disclosed |
| US-12186947-B2 | Low-pore pellets and method for producing molded body | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-01-07 | — | — | US | disclosed |
| US-12180344-B2 | Cellulose nanofiber-containing aqueous dispersion | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-12-31 | — | — | US | disclosed |
| US-20240328481-A1 | Cellulose-containing Gear | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-10-03 | — | — | US | disclosed |
| EP-3786215-B1 | CELLULOSE NANOFIBER-CONTAINING AQUEOUS DISPERSION AND CELLULOSE NANOFIBER-CONTAINING RESIN COMPOSITION | ASAHI CHEMICAL IND (JP) | 2024-09-25 | — | — | EP | disclosed |
| US-20240270948-A1 | RESIN COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2024-08-15 | — | — | US | disclosed |
| US-20240240027-A1 | METHOD FOR PRODUCING MODIFICATION INORGANIC NANOSHEET, AND MODIFICATION INORGANIC NANOSHEET | FUKUOKA INSTITUTE OF TECHNOLOGY (JP) | 2024-07-18 | — | — | US | disclosed |
| US-12007001-B2 | Cellulose-containing gear | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-06-11 | — | — | US | disclosed |
| EP-4040018-B1 | A MOLDED ARTICLE | ASAHI CHEMICAL IND (JP) | 2024-05-22 | — | — | EP | disclosed |
| US-20120296076-A1 | PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS | GILEAD SCIENCES, INC. | 2012-11-22 | — | — | US | disclosed |
| CN-102432862-A | Modified alkoxylation products having at least one non-terminal alkoxysilyl group, with increased storage life and increased stretchability of the polymers prepared using them | EVONIK GOLDSCHMIDT GMBH | 2012-05-02 | — | — | CN | disclosed |
| EP-1480943-A2 | SYNTHESIS OF 3,5-DIHYDROXY-7-PYRROL-1-YL HEPTANOIC ACIDS | Teva Pharmaceutical Industries Limited (IL) | 2004-12-01 | — | — | EP | disclosed |
| WO-2004046105-A2 | SYNTHESIS OF 3,5-DIHYDROXY-7-PYRROL-1-YL HEPTANOIC ACIDS | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2004-06-03 | — | — | WO | disclosed |
| US-6703497-B1 | SURFACE MODIFIED BY HAVING HYDROXYL FUNCTIONAL GROUPS PRESENT AT THE SURFACE ETHERIFIED BY ORGANIC COMPOUND COMPRISING SILYLATING AGENT, ISOCYANATE, HALOGENATED ALKYLATING AGENT, ALKYLENE OXIDE, OR GLYCIDYL COMPOUND | RHODIA CHIMIE (FR) | 2004-03-09 | — | — | US | disclosed |
| EP-0200141-A2 | Photoresist composition | NIPPON ZEON CO., LTD. (JP) | 1986-11-05 | — | — | EP | disclosed |
| EP-0031962-B1 | FUNGICIDAL AZOLYL-SILYL-GLYCOL ETHERS, THEIR PREPARATION, THEIR USE TO COMBAT FUNGI AND COMPOSITION THEREFOR | BASF Aktiengesellschaft (DE) | 1983-02-09 | — | — | EP | disclosed |
| US-4330535-A | Fungicidal azolyl-silyl-glycol ethers, their use for combating fungi, and agents therefor | BASF AKTIENGESELLSCHAFT (DE) | 1982-05-18 | — | — | US | disclosed |
| EP-0031962-A2 | Fungicidal azolyl-silyl-glycol ethers, their preparation, their use to combat fungi and composition therefor | BASF Aktiengesellschaft (DE) | 1981-07-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120296076-A1 | PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS | SAMHD1, DHPS, LSS | KDM4E 1951/4885ALDH1A1 2236/4885TDP1 1786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.